Hypofractionated whole breast radiotherapy: current perspectives
Theodora A Koulis, Tien Phan, Ivo A Olivotto Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada Abstract: Adjuvant radiotherapy (RT) is an important part of breast cancer management but the dose and fractionation schedules used are variable. A total of 50 Gy...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/71752a5c1f8f4175b09e57ed0052c00f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:71752a5c1f8f4175b09e57ed0052c00f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:71752a5c1f8f4175b09e57ed0052c00f2021-12-02T06:49:40ZHypofractionated whole breast radiotherapy: current perspectives1179-1314https://doaj.org/article/71752a5c1f8f4175b09e57ed0052c00f2015-10-01T00:00:00Zhttps://www.dovepress.com/hypofractionated-whole-breast-radiotherapy-current-perspectives-peer-reviewed-article-BCTThttps://doaj.org/toc/1179-1314Theodora A Koulis, Tien Phan, Ivo A Olivotto Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada Abstract: Adjuvant radiotherapy (RT) is an important part of breast cancer management but the dose and fractionation schedules used are variable. A total of 50 Gy in 25 daily fractions delivered over 5 weeks is often considered the "standard" adjuvant RT prescription. Hypofractionated regimes such as 42.5 Gy in 16 daily fractions or 40 Gy in 15 daily fractions following breast-conserving surgery have proven to be equally effective and achieve similar or better cosmetic and normal tissue outcomes for both invasive and in situ diseases and when treating the regional nodes. Hypofractionation is more convenient for patients and less costly. However, certain patients at higher risk of RT late effects may benefit from a less intense, even more extended fractionation schedule. This review describes the indications for whole breast hypofractionated adjuvant RT for patients with breast cancer following breast-conserving surgery and proposes that hypofractionation should be the new "standard" for adjuvant breast cancer RT. Keywords: fractionation, breast cancer, cosmesis, radiotherapyKoulis TAPhan TOlivotto IADove Medical PressarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBreast Cancer: Targets and Therapy, Vol 2015, Iss default, Pp 363-370 (2015) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Koulis TA Phan T Olivotto IA Hypofractionated whole breast radiotherapy: current perspectives |
description |
Theodora A Koulis, Tien Phan, Ivo A Olivotto Department of Oncology, University of Calgary, Tom Baker Cancer Centre, Calgary, AB, Canada Abstract: Adjuvant radiotherapy (RT) is an important part of breast cancer management but the dose and fractionation schedules used are variable. A total of 50 Gy in 25 daily fractions delivered over 5 weeks is often considered the "standard" adjuvant RT prescription. Hypofractionated regimes such as 42.5 Gy in 16 daily fractions or 40 Gy in 15 daily fractions following breast-conserving surgery have proven to be equally effective and achieve similar or better cosmetic and normal tissue outcomes for both invasive and in situ diseases and when treating the regional nodes. Hypofractionation is more convenient for patients and less costly. However, certain patients at higher risk of RT late effects may benefit from a less intense, even more extended fractionation schedule. This review describes the indications for whole breast hypofractionated adjuvant RT for patients with breast cancer following breast-conserving surgery and proposes that hypofractionation should be the new "standard" for adjuvant breast cancer RT. Keywords: fractionation, breast cancer, cosmesis, radiotherapy |
format |
article |
author |
Koulis TA Phan T Olivotto IA |
author_facet |
Koulis TA Phan T Olivotto IA |
author_sort |
Koulis TA |
title |
Hypofractionated whole breast radiotherapy: current perspectives |
title_short |
Hypofractionated whole breast radiotherapy: current perspectives |
title_full |
Hypofractionated whole breast radiotherapy: current perspectives |
title_fullStr |
Hypofractionated whole breast radiotherapy: current perspectives |
title_full_unstemmed |
Hypofractionated whole breast radiotherapy: current perspectives |
title_sort |
hypofractionated whole breast radiotherapy: current perspectives |
publisher |
Dove Medical Press |
publishDate |
2015 |
url |
https://doaj.org/article/71752a5c1f8f4175b09e57ed0052c00f |
work_keys_str_mv |
AT koulista hypofractionatedwholebreastradiotherapycurrentperspectives AT phant hypofractionatedwholebreastradiotherapycurrentperspectives AT olivottoia hypofractionatedwholebreastradiotherapycurrentperspectives |
_version_ |
1718399696049799168 |